Lyra Mucosal Tissue Equipment
2 equipment items found
-
Manufactured by Lyra Therapeutics, Inc.based in USA
Lyra’s lead product candidate, LYR-210, to treat chronic rhinosinusitis (CRS), an inflammatory disease of the paranasal sinuses. LYR-210 is an anti-inflammatory implantable drug matrix based upon Lyra’s XTreo™ platform designed to elute mometasone furoate consistently and locally to the inflamed mucosal tissue of ...
-
Manufactured by Lyra Therapeutics, Inc.based in USA
LYR-220, Lyra’s second product candidate, is in Phase 2 development for the millions of chronic rhinosinusitis (CRS) patients who have undergone a prior sinus surgery but continue to have persistent ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you